Diversified Healthcare Trust vs Omega Healthcare Investors
DHC and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DHC and OHI compare
Omega Healthcare Investors is the larger company, worth 7.4 times as much as Diversified Healthcare Trust ($14.2B against $1.9B).
Omega Healthcare Investors grew revenue faster over the last twelve months (15.0% versus −1.5% for Diversified Healthcare Trust).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with −17.7% at Diversified Healthcare Trust.
Both pay dividends: Diversified Healthcare Trust yields 0.50% and Omega Healthcare Investors 5.7%.
Omega Healthcare Investors scores higher on the StockData Score (12 against 1 for Diversified Healthcare Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DHC | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $14.2B |
| Share price | $7.97 | $46.98 |
| Change, 1 year | 91.1% | 18.8% |
| Change, 5 years | 123% | 57.0% |
| Beta (5Y) | 1.09 | 0.27 |
| Employees | 600 | 69 |
| StockData Score | ||
| Total score | 1 | 12 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 0 | 0 |
| Dividend score | 1 | 4 (better) |
| Valuation | ||
| P/E | – | 17.0× |
| P/S | 1.3× (better) | 11.1× |
| P/B | 1.2× (better) | 2.6× |
| EV/EBITDA | 14.5× | 10.0× (better) |
| PEG | – | 6.71 |
| Fair value | $4.45 | $52.14 |
| Margin of safety | −78.9% | 9.9% (better) |
| Growth | ||
| Revenue growth (TTM) | −1.5% | 15.0% (better) |
| Revenue growth, 5Y average | −1.2% | 5.9% (better) |
| Net income growth (TTM) | – | 82.4% |
| EPS growth (TTM) | – | 73.1% |
| EPS growth, 5Y average | – | 22.6% |
| Profitability | ||
| Net margin | −17.7% | 67.0% (better) |
| Return on equity | −15.5% | 16.5% (better) |
| Financial health | ||
| Altman Z-score | 1.13 | 2.81 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.50% | 5.7% (better) |
| Payout ratio | – | 92.6% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −26.0% | 0.00% (better) |
| Buyback yield | 0.06% | – |
| Shareholder yield | 0.56% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 84.9% | 81.8% |
| Held by insiders | 15.2% | 0.19% |
| Insider net buying, 12 months | $97.8K | $1.4M (better) |
| Short interest, % of float | – | 5.2% |
Go deeper
- DHC stock overview
- DHC income statement
- DHC valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.